Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin P Robertson

Showing results (41-50 of 111) with videos related to

Pageof 12
Sort By:
Cancer Research|July 9, 2010
Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis developmentSung Jin Huh, Shile Liang, Arati Sharma, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 8, 2010
Sequential binding of αVβ3 and ICAM-1 determines fibrin-mediated melanoma capture and stable adhesion to CD11b/CD18 on neutrophilsPu Zhang, Tugba Ozdemir, Chin-Ying Chung, et al.
Immunology|November 3, 2018
Aldehyde dehydrogenase in regulatory T-cell development, immunity and cancerChristopher G Bazewicz, Saketh S Dinavahi, Todd D Schell, et al.
Cancer Biology & Therapy|June 7, 2012
Selenium-containing histone deacetylase inhibitors for melanoma managementRaghavendra Gowda, Subbarao V Madhunapantula, Dhimant Desai, et al.
Advances in Experimental Medicine and Biology|January 5, 2013
Current and future trials of targeted therapies in cutaneous melanomaMatthew S Evans, Subbarao V Madhunapantula, Gavin P Robertson, et al.
Molecular Cancer Therapeutics|November 1, 2012
Simultaneous targeting of COX-2 and AKT using selenocoxib-1-GSH to inhibit melanomaRaghavendra Gowda, Subbarao V Madhunapantula, Dhimant Desai, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 4, 2011
Melanoma prevention using topical PBISeChin-Ying Chung, SubbaRao V Madhunapantula, Dhimant Desai, et al.
Frontiers in Oncology|July 9, 2020
Salubrinal in Combination With 4E1RCat Synergistically Impairs Melanoma Development by Disrupting the Protein Synthetic MachineryGregory R Kardos, Raghavendra Gowda, Saketh Sriram Dinavahi, et al.
Molecular Cancer Therapeutics|April 2, 2014
Targeting multiple key signaling pathways in melanoma using leelamineRaghavendra Gowda, SubbaRao V Madhunapantula, Omer F Kuzu, et al.
Molecular Cancer Therapeutics|August 2, 2014
Nanolipolee-007, a novel nanoparticle-based drug containing leelamine for the treatment of melanomaRaghavendra Gowda, SubbaRao V Madhunapantula, Arati Sharma, et al.
Pageof 12

Showing results (41-50 of 111) with videos related to

Sort By:
Pageof 12
Cancer Research|July 9, 2010
Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis developmentSung Jin Huh, Shile Liang, Arati Sharma, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 8, 2010
Sequential binding of αVβ3 and ICAM-1 determines fibrin-mediated melanoma capture and stable adhesion to CD11b/CD18 on neutrophilsPu Zhang, Tugba Ozdemir, Chin-Ying Chung, et al.
Immunology|November 3, 2018
Aldehyde dehydrogenase in regulatory T-cell development, immunity and cancerChristopher G Bazewicz, Saketh S Dinavahi, Todd D Schell, et al.
Cancer Biology & Therapy|June 7, 2012
Selenium-containing histone deacetylase inhibitors for melanoma managementRaghavendra Gowda, Subbarao V Madhunapantula, Dhimant Desai, et al.
Advances in Experimental Medicine and Biology|January 5, 2013
Current and future trials of targeted therapies in cutaneous melanomaMatthew S Evans, Subbarao V Madhunapantula, Gavin P Robertson, et al.
Molecular Cancer Therapeutics|November 1, 2012
Simultaneous targeting of COX-2 and AKT using selenocoxib-1-GSH to inhibit melanomaRaghavendra Gowda, Subbarao V Madhunapantula, Dhimant Desai, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 4, 2011
Melanoma prevention using topical PBISeChin-Ying Chung, SubbaRao V Madhunapantula, Dhimant Desai, et al.
Frontiers in Oncology|July 9, 2020
Salubrinal in Combination With 4E1RCat Synergistically Impairs Melanoma Development by Disrupting the Protein Synthetic MachineryGregory R Kardos, Raghavendra Gowda, Saketh Sriram Dinavahi, et al.
Molecular Cancer Therapeutics|April 2, 2014
Targeting multiple key signaling pathways in melanoma using leelamineRaghavendra Gowda, SubbaRao V Madhunapantula, Omer F Kuzu, et al.
Molecular Cancer Therapeutics|August 2, 2014
Nanolipolee-007, a novel nanoparticle-based drug containing leelamine for the treatment of melanomaRaghavendra Gowda, SubbaRao V Madhunapantula, Arati Sharma, et al.
Pageof 12